FRIDAY HARBOR, WA--(Marketwired - May 19, 2015) -  Strategic News Service (SNS) is proud to announce that Nanotech Biomachines has been selected as a 2015 FiReStarter company to be featured at the 13th annual Future in Review (FiRe) conference. Described by The Economist as "the best technology conference in the world," FiRe features global thought leaders in technology and the global economy, including Elon Musk, Craig Venter, Michael Dell, Vint Cerf, Leroy Hood, Patti Grace Smith, Mark Hurd, Paul Jacobs, and many others. FiReStarters are selected based on the strength of their innovations and their potential to bring positive change to the world, and are showcased at an exclusive investor reception at the FiRe conference, in panels throughout the event, and with ongoing relationships introduced and supported by SNS.

Nanotech Bio is an innovative sensor company based in Berkeley, CA. Nanotech Bio is emerging as the Intel (brain) and Nest (smart sensors) of biotechnology by providing a sensor solution that does not exist in the biotech market. Its first product, the NanoChip, is the first real-time electronic tool to acquire critical biological parameters to accelerate the development of biotherapeutics. When consumers pay thousands of dollars for drugs to treat cancers, neurodegenerative, and deadly chronic diseases, they pay not only for their $4,000 branded drug dose, but also for the other 25+ projects that failed in the clinic before their drugs reached the market. This risky process, limited by the absence of reliable tools for drug development, makes drugs extremely expensive and unreachable to many patients. Nanotech Bio's sensor technology will accelerate and bring unparalleled reliability to the drug development process. Despite its early stage, Nanotech Bio has established major collaborations and commercial relations with biotech industry leaders that are gaining early access to Nanotech Bio's innovative sensor products.

"I envision a world where people won't die because they cannot afford to buy their branded drugs," said Will Martinez, CEO and CTO of Nanotech Bio.

"Finding a substrate that allows a combination of small-scale electrical conductivity, inert chemical behavior, and long life has led the research team at Nanotech Bio to a leadership position in biosensors. We are delighted to have Nanotech Bio as a FiReStarter company this year, and we look forward to its continued success in teaching us about human biology on a nano scale," said Mark Anderson, FiRe chair and CEO of the Strategic News Service.

Future in Review is a gathering of world-class thought leaders, convened each year with the goal of providing the most accurate look forward in technology. FiRe is a world leader in exploring how technology drives the world economy and in using technology to solve major social challenges. These goals have been consistently achieved through FiRe's collaboration across technology-driven industries and through active support from the global FiRe community. Now in its 13th year, FiRe 2015 will take place October 6-9, 2015, at the Stein Eriksen Lodge Deer Valley in Park City, Utah.

To register for FiRe 2015, go to www.futureinreview.com.

Strategic News Service was founded by Mark Anderson in 1995 as the first subscription-based online news service. Since its inception, SNS has proven the most accurate predictive report covering technology and the global economy. Its subscribers include top managers at technology and finance companies across the globe, including Oracle, Microsoft, HP, Dell, Cisco, Intel, Google, British Telecom, SpaceX, Amazon, Telstra, and others.

SNS has been operating the annual FiRe conference since 2003. FiRe exposes world experts and participants to new ideas, and conversations about them, producing an accurate portrait of the future; and focuses on creating technology solutions to current local and global problems. FiRe 2015 will take place October 6-9, 2015, at the Stein Eriksen Lodge Deer Valley in Park City, Utah. For more information and to register, go to www.futureinreview.com.

Future in Review is a Strategic News Service conference. Future in Review and Strategic News Service (SNS) are registered international trademarks. The "SNS Global Report" is the most accurate publicly ranked predictive newsletter in computing and communications.

Websites: www.stratnews.com, www.futureinreview.com

About Nanotech Biomachines, Inc. ("Nanotech Bio") is the emerging Intel & Nest of Biotech.

Nanotech Bio's proprietary product, the NanoChip sensor acquires critical biological parameters in real-time to accelerate the development of bio therapeutics. The Company's mission is to accelerate and make the drug development process far more cost-effective to make branded drugs more affordable for patients. When consumers pay thousands of dollars for drugs to treat cancers, neurodegenerative, and deadly chronic diseases, they pay not only for their $4000 branded drug dose, but also for the other 25+ projects that failed in the clinic before their drugs reached the market. This risky process, limited by the absence of reliable tools for drug development, makes drugs extremely expensive and unreachable to many patients. Nanotech Bio's sensor technology will accelerate and bring unparalleled reliability to the drug development process. www.nanotechbio.com

Contact Information:

Press Contact:
Sally Anderson
Strategic News Service
sally@stratnews.com